Fenghe received his Ph.D. in Physical Chemistry from Chinese Academy of Sciences and a BS degree in Chemistry from Shandong University, China.
He has been with Boehringer Ingelheim Pharmaceuticals Inc. for 16 years and currently is a Senior Research Fellow in the department of Material and Analytical Sciences.
His primary responsibility involves analytical development of small molecule entities which includes providing leadership in impurity elucidation and mutagenic impurity risk assessment and control.
He is the current organizer of the GTI Advisory Council within the company.
Prior to BI, Fenghe had several academic assignments including, Mass Spectrometry Lab Manager, Department of Chemistry, Northwestern University; Associate Professor, National Center of Biomedical Analysis of China.